Japan’s century-old ASKA Pharmaceutical Co., Ltd plans to increase its stake in Ha Tay Pharmaceutical JSC, traded on the Hanoi Stock Exchange as DHT, to 33%.
Share
An engineer works on a machine in DHG Pharmaceutical Co’s drug manufacturing plant in Can Tho city. Vietnam’s pharmaceutical industry is expected to recover and grow by 15 per cent this year. VIETNAM NEWS AGENCY/VIET NAM NEWS
VN pharma market forecast to grow 15%
Tue, 23 February 2021
Vietnam s pharmaceutical industry grew by just 2.8 per cent last year, much lower than its average 11.8 per cent growth in the last five years.
It is expected to recover and grow by 15 per cent this year, mainly due to a rapidly ageing population and increasing incomes, analysts at SSI Securities Corp said.
According to a report by the company, social distancing and strict control at hospitals last year meant people with minor ailments did not go for treatment due, resulting in lower sales of both prescription and non-prescription drugs.
Pharma industry growth slows down
By Minh Son February 1, 2021 | 08:59 am GMT+7
SSI analysts estimated the pharmaceutical industry to grow by 15 percent in 2021. Photo by Pixabay.
The pharmaceutical industry’s revenues rose by just 3 percent in 2020, down from an average of 11.8 percent in the previous five years.
But it was a notable year for mergers and acquisitions. According to analysts at SSI Securities, the total value of M&A was VND1.68 trillion ($73 million) last year and involved a number of foreign investors.
In May, South Korean conglomerate SK Group, which makes anti-cancer and cardiovascular drugs and mental health medications, paid VND920 billion to acquire a 25 percent stake in Imexpharm Pharmaceutical Joint Stock Company.